StockData
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc. (CRDL) stock

CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)

Close on Nov 20, 2026Market cap $86.48MP/E –Yield –

Cardiol Therapeutics cash

Cash and short-term investments held at the end of each period.

Cardiol Therapeutics's cash was C$21.42M at Dec 31, 2025. For fiscal 2025 it was C$21.42M, down 30.0% from the year before. The highest annual figure on record is C$83.90M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025C$21.42M-30.0%
FY2024Dec 31, 2024C$30.58M-12.5%
FY2023Dec 31, 2023C$34.93M-41.3%
FY2022Dec 31, 2022C$59.47M-29.1%
FY2021Dec 31, 2021C$83.90M+498.2%
FY2020Dec 31, 2020C$14.03M+101.6%
FY2019Dec 31, 2019C$6.96M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025C$21.42M-74.5%
Q4 FY2024Dec 31, 2024C$30.58M+118.0%
Q4 FY2023Dec 31, 2023C$34.93M+402.2%
Q4 FY2022Dec 31, 2022C$59.47M–
Q4 FY2021Dec 31, 2021C$83.90M–
Q4 FY2020Dec 31, 2020C$14.03M–
Q4 FY2019Dec 31, 2019C$6.96M–

More Cardiol Therapeutics figures

See a number that looks wrong?